Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
MDRX Stock Overview
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.
Allscripts Healthcare Solutions Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$17.30 |
52 Week High | US$23.25 |
52 Week Low | US$13.05 |
Beta | 0.98 |
1 Month Change | -20.90% |
3 Month Change | -14.95% |
1 Year Change | -1.03% |
3 Year Change | 70.11% |
5 Year Change | 51.62% |
Change since IPO | 218.02% |
Recent News & Updates
We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Shareholder Returns
MDRX | US Healthcare Services | US Market | |
---|---|---|---|
7D | 2.1% | 4.0% | 1.0% |
1Y | -1.0% | -40.3% | -15.1% |
Return vs Industry: MDRX exceeded the US Healthcare Services industry which returned -40.1% over the past year.
Return vs Market: MDRX exceeded the US Market which returned -13.2% over the past year.
Price Volatility
MDRX volatility | |
---|---|
MDRX Average Weekly Movement | 5.2% |
Healthcare Services Industry Average Movement | 12.5% |
Market Average Movement | 7.8% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MDRX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: MDRX's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 8,000 | Rick Poulton | https://www.allscripts.com |
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm.
Allscripts Healthcare Solutions Fundamentals Summary
MDRX fundamental statistics | |
---|---|
Market Cap | US$2.01b |
Earnings (TTM) | US$148.15m |
Revenue (TTM) | US$1.51b |
13.5x
P/E Ratio1.3x
P/S RatioIs MDRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDRX income statement (TTM) | |
---|---|
Revenue | US$1.51b |
Cost of Revenue | US$763.23m |
Gross Profit | US$748.83m |
Other Expenses | US$600.68m |
Earnings | US$148.15m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 1.28 |
Gross Margin | 49.52% |
Net Profit Margin | 9.80% |
Debt/Equity Ratio | 27.9% |
How did MDRX perform over the long term?
See historical performance and comparisonValuation
Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MDRX ($17.3) is trading below our estimate of fair value ($36.25)
Significantly Below Fair Value: MDRX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: MDRX is good value based on its Price-To-Earnings Ratio (13.5x) compared to the US Healthcare Services industry average (46.5x).
PE vs Market: MDRX is good value based on its Price-To-Earnings Ratio (13.5x) compared to the US market (14.9x).
Price to Earnings Growth Ratio
PEG Ratio: MDRX is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: MDRX is good value based on its Price-To-Book Ratio (1.5x) compared to the US Healthcare Services industry average (2x).
Future Growth
How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
8.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDRX's forecast earnings growth (8% per year) is above the savings rate (1.9%).
Earnings vs Market: MDRX's earnings (8% per year) are forecast to grow slower than the US market (12.1% per year).
High Growth Earnings: MDRX's earnings are forecast to grow, but not significantly.
Revenue vs Market: MDRX's revenue is expected to decline over the next 3 years (-2.2% per year).
High Growth Revenue: MDRX's revenue is forecast to decline over the next 3 years (-2.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MDRX's Return on Equity is forecast to be high in 3 years time
Past Performance
How has Allscripts Healthcare Solutions performed over the past 5 years?
Past Performance Score
2/6Past Performance Score 2/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
20.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDRX has a large one-off gain of $59.1M impacting its March 31 2022 financial results.
Growing Profit Margin: MDRX became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: MDRX has become profitable over the past 5 years, growing earnings by 20.2% per year.
Accelerating Growth: MDRX has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MDRX has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.5%).
Return on Equity
High ROE: MDRX's Return on Equity (10.9%) is considered low.
Financial Health
How is Allscripts Healthcare Solutions's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: MDRX's short term assets ($1.5B) exceed its short term liabilities ($646.9M).
Long Term Liabilities: MDRX's short term assets ($1.5B) exceed its long term liabilities ($430.3M).
Debt to Equity History and Analysis
Debt Level: MDRX's net debt to equity ratio (21.7%) is considered satisfactory.
Reducing Debt: MDRX's debt to equity ratio has reduced from 82.5% to 27.9% over the past 5 years.
Debt Coverage: MDRX's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: MDRX's interest payments on its debt are well covered by EBIT (20.1x coverage).
Balance Sheet
Dividend
What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MDRX has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
2.2yrs
Average management tenure
CEO
Rick Poulton (56 yo)
no data
Tenure
US$7,613,839
Compensation
Mr. Richard J. Poulton, also known as Rick, serves as Chief Executive Officer at Allscripts Healthcare Solutions, Inc. since May 06, 2022. Mr. Poulton served as the President of Allscripts Healthcare Solut...
CEO Compensation Analysis
Compensation vs Market: Rick's total compensation ($USD7.61M) is above average for companies of similar size in the US market ($USD5.44M).
Compensation vs Earnings: Rick's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: MDRX's management team is considered experienced (2.2 years average tenure).
Board Members
Experienced Board: MDRX's board of directors are considered experienced (6 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MDRX insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Allscripts Healthcare Solutions, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Allscripts Healthcare Solutions, Inc.
- Ticker: MDRX
- Exchange: NasdaqGS
- Founded: 1986
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: US$2.007b
- Shares outstanding: 116.02m
- Website: https://www.allscripts.com
Number of Employees
Location
- Allscripts Healthcare Solutions, Inc.
- 222 Merchandise Mart Plaza
- Suite 2024
- Chicago
- Illinois
- 60654
- United States
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/25 00:00 |
End of Day Share Price | 2022/05/25 00:00 |
Earnings | 2022/03/31 |
Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.